Prevalence of hepatitis A IgG in individuals with chronic hepatitis B infection in Babol

Eastern Mediterranean Health Journal

Volumn 13, Issue 5, 2007, Pages 1108-1113

  Roushan, M R Hagar ^a   Bijani, A ^a   Sagheb, R ^a   Jazayeri, O ^b  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF MAZANDARAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; IRAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; SCHOOL CHILD; SEROPREVALENCE;

EID: 37849004071     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2007.13.5.1108     Document Type: Article

References (32)

1. Feinstone SM, Gust ID. Hepatitis A. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 5th ed. Philadelphia, Churchill Livingstone, 2000, 2:1920-40.
2. Shapiro CN et al. Epidemiology of hepatitis A in the United States. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral hepatitis and liver disease. Baltimore, Williams & Wilkins, 1991:71.
3. Keeffe FB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver disease? American journal of gastroenterology, 1996, 90:201-5.
4. Vento S et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. New England journal of medicine, 1998, 338(5):286-90.
5. Pramoolsinsap C et al. Acute hepatitis A super-infection in HBV carriers, or chronic liver disease related to HBV or HCV. Annals of tropical medicine and parasitology, 1999, 93(7):745-51.
6. Tsang SW, Sung JJ. Inactivated hepatitis A vaccine in Chinese patients with chronic hepatitis B infection. Alimentary pharmacology & therapeutics, 1999, 13(11):1445-9.
7. Yao G. Clinical spectrum and natural history of viral hepatitis A in a 1988 Shanghai epidemic. In: Hollinger FB, Lemon SM, Margolis H, eds. Viral hepatitis and liver disease. Baltimore, Williams & Wilkins, 1991:76-8.
8. Mehr AJ et al. Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. European journal of epidemiology, 2004, 19(3):275-8.
9. Das K et al. The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries. European journal of epidemiology, 2000, 16(6):507-10.
10. Tapia-Conyer R et al. Hepatitis A in Latin America: a changing epidemiologic pattern. American journal of tropical medicine & hygiene, 1999, 61(5):825-9.
11. Wong KH et al. Epidemiology of hepatitis A and E infection and their determinants in adult Chinese community in Hong Kong. Journal of medical virology, 2004, 72(4):538-44.
12. Antaki N, Kebbewar MK. Hepatitis A sero-prevalence rate in Syria. Tropical doctor, 2000, 30(2):99-101.
13. Joshi N, Yr NK, Kumar A. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India. Tropical gastroenterology, 2000, 21(2):63-5.
14. Mall ML et al. Seroepidemiology of hepatitis A infection in India: changing pattern. Indian journal of gastroenterology, 2001, 20(4): 132-5.
15. Saffar MJ, Hammatabadi MA. [Seroepidemiological study on hepatitis A in different age groups of children in Sari during 1997-98]. Nammeh daneshgah, 1999, 9 (22/23):1-5 [in Farsi].
16. Salehi M, Sanei ME. [Seroepidemiology of hepatitis A in population under 30 years old in rural area of Zabol]. Journal of Medical Faculty, Guilan University of Medical Sciences, 2001, 10(39/40):26-9 [in Farsi].
17. Alborzi P. [Age groups who need gamma globulins in contact with hepatitis A]. Paper presented at the 7th Congress on Infectious Diseases and Tropical Medicine, Babolsar, Islamic Republic of Iran, 1998 [in Farsi].
18. Dal-Ré R, García-Corberia P, García-de-Lomas J. A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A. Journal of medical virology, 2000, 60(4):363-6.
19. Gonzalez A et al. Encuesta seroepidemiológica de prevalencia de anticuerpos antihepatitis A en la población adulta joven española [Seroepidemiologic survey of hepatitis A antibodies in the young adult Spanish population]. Medicina clinica, 1994, 103(12):445-8.
20. Polz-Dacewicz MA, Policzkiewicz P, Badach Z. Changing epidemiology of hepatitis A virus infection - a comparative study in central eastern Poland (1990-1999). Medical science monitor, 2000, 6(5):989-93.
21. Moschen ME et al. Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy. European journal of epidemiology, 1997, 13(8):875-8.
22. Roy E et al. Seroprevalence and risk factors for hepatitis A among Montreal street youth. Canadian journal of public health, 2002, 93(1):52-3.
23. Catania S et al. Studio sieroepidemiologico della prevalenza degli anticorpi anti HAV nei bambini di Roma e Provincia [Seroepidemiologic study of the prevalence of anti-HAV antibodies in children in Rome]. Revista europea per le scienze mediche e farmacologiche, 1996, 18(1):7-9.
24. Santana OE et al. Estudio seroepidemiológico de hepatitis A en Gran Canaria [Seroepidemiological study of hepatitis A in Gran Canaria (Spain)]. Enfermedades infecciosas y microbiologia clinica, 2000, 18(4):170-3.
25. Kunasol P et al. Hepatitis A virus: declining seroprevalence in children and adolescents in Southeast Asia. Southeast Asian journal of tropical medicine and public health, 1998, 29(2):255-62.
26. Tufenkeji H. Hepatitis A shifting epidemiology in the Middle East and Africa. Vaccine, 2000, 18(Suppl. 1):S65-7.
27. Erdogan MS et al. The epidemiology of hepatitis A virus infection in children, in Edirne, Turkey. European journal of epidemiology, 2004, 19(3):267-73.
28. Sidal M et al. Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey. European journal of epidemiology, 2001, 17(2):141-4.
29. Colak D et al. Seroprevalence of antibodies to hepatitis A and E viruses in pediatric age groups in Turkey. Acta microbiologica et immunologica hungarica, 2002, 49(1):93-7.
30. Foussal MD, Picon C, Sorrentino A. Hepatitis A en la infancia. La punta del iceberg infectológico [Hepatitis A in childhood. The tip of an infectious disease iceberg]? Acta gastroenterologica latinoamericana, 2002, 32:101-5.
31. Arankalle VA, Chadha MS. Who should receive hepatitis A vaccine? Journal of viral hepatitis, 2003, 10(3): 157-8.
32. Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clinical microbiology reviews, 1999, 12(2)357-66.